Related Experiment Video
Updated: Jul 15, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
WTH3 is a direct target of the p53 protein
1Department of Biochemistry and Cell Biology, State University of New York at Stony Brook, Stony Brook, NY, USA.
Abstract:
Previous results showed that overexpression of the WTH3 gene in multidrug resistance (MDR) cells reduced MDR1 gene expression and converted their resistance to sensitivity to various anticancer drugs. The WTH3 gene promoter was found to be differentially regulated in paired MDR vs non-MDR MCF7 cells owing to epigenetic modifications and transcription factor modulations. To understand further the mechanisms that govern WTH3's differential expression, we uncovered a p53-binding site in its promoter, which indicated that WTH3 could be regulated by the p53 gene. This hypothesis was then tested by different strategies. The resulting data revealed that (1) the WTH3 promoter was upregulated by the p53 transgene in diverse host cells; (2) there was a correlation between WTH3 expression levels and p53 gene status in a cell line panel; (3) a WTH3 promoter region was directly targeted by the p53 protein in vitro and in vivo. In addition, overexpression of the WTH3 gene promoted the apoptotic phenotype in host cells. On the basis of these findings, we believe that the negative role played by the WTH3 gene in MDR development is through its proapoptotic potential that is regulated by multiple mechanisms at the transcription level, and one of these mechanisms is linked to the p53 gene.
Insights
The WTH3 gene, regulated by p53, can reverse multidrug resistance (MDR) in cancer cells by promoting apoptosis. This discovery offers new insights into overcoming MDR development through gene regulation strategies.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Multidrug resistance (MDR) in cancer cells poses a significant challenge to chemotherapy.
- Previous studies indicated WTH3 gene overexpression reduces MDR and restores sensitivity to anticancer drugs.
- Differential regulation of the WTH3 gene promoter in MDR cells suggests underlying epigenetic and transcription factor involvement.
Purpose of the Study:
- To elucidate the regulatory mechanisms governing the differential expression of the WTH3 gene.
- To investigate the potential role of the p53 gene in regulating WTH3 expression.
- To understand how WTH3 influences multidrug resistance and apoptosis in cancer cells.
Main Methods:
- Identification of a p53-binding site within the WTH3 promoter region.
- Experimental validation of p53-mediated WTH3 promoter activity using transgenes.
- Correlation analysis of WTH3 expression and p53 gene status across various cell lines.
- In vitro and in vivo studies to confirm direct p53 protein targeting of the WTH3 promoter.
Main Results:
- The p53 transgene significantly upregulated the WTH3 promoter in different host cells.
- A direct correlation was observed between WTH3 expression levels and p53 gene status.
- The p53 protein was confirmed to directly target a specific region of the WTH3 promoter.
- Overexpression of WTH3 induced an apoptotic phenotype in host cells.
Conclusions:
- The WTH3 gene's negative role in MDR development is mediated through its proapoptotic function.
- WTH3 expression is regulated at the transcriptional level by multiple mechanisms, including direct p53 gene involvement.
- These findings highlight the p53-WTH3 axis as a potential therapeutic target for overcoming multidrug resistance in cancer.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway
PI3K/mTOR/AKT Signaling Pathway

